Collegium Pharmaceutical
COLL
157 hedge funds and large institutions have $646M invested in Collegium Pharmaceutical in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 68 reducing their positions, and 25 closing their positions.
219% more call options, than puts
Call options by funds: $628K | Put options by funds: $197K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.85% less ownership
Funds ownership: 108.09% → 107.24% (-0.85%)
9% less funds holding
Funds holding: 172 → 157 (-15)
12% less capital invested
Capital invested by funds: $734M → $646M (-$88.4M)
24% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 68
32% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Principal Financial Group
Des Moines,
Iowa
|
+$5.4M |
| 2 |
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Chicago,
Illinois
|
+$5.37M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$4.35M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.04M |
| 5 |
RA
Royce & Associates
New York
|
+$2.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$4.5M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$4.41M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$2.7M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$2.49M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$2.16M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
176
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | -$1K | -66 | Closed |
|
|
FPS
177
Fieldpoint Private Securities
Greenwich,
Connecticut
| – | -$1K | -50 | Closed |
|
|
C
178
Covestor
London,
United Kingdom
| – | -$437 | -26 | -81% |
|
COLL Hedge Fund Activity: Q2 2022 in Review
157 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q2 2022, worth a combined $646M — down 12% from $734M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of COLL and 17 opened new positions — a net loss of 8 holders — while 68 trimmed existing stakes and 52 added.
The largest buyer was Principal Financial Group, adding an estimated $5.4M. The largest seller was Pacer Advisors, exiting entirely with an estimated $4.5M sold.
- 157 institutional investors held Collegium Pharmaceutical (COLL) as of Q2 2022, down from 172 in Q1 2022.
- Funds reported $646M of Collegium Pharmaceutical stock for Q2 2022, down 12% quarter-over-quarter.
- 17 funds opened new Collegium Pharmaceutical positions in Q2 2022 and 25 closed out, a net change of -8 holders.
- The largest Collegium Pharmaceutical buyer in Q2 2022 was Principal Financial Group, an estimated $5.4M added.
- The largest Collegium Pharmaceutical seller in Q2 2022 was Pacer Advisors, an estimated $4.5M sold.
Based on aggregated 13F filings for Q2 2022.